Overview
As most Dual Eligibles have a qualifying chronic condition, the difference between C-SNPs and D-SNPs are becoming less pronounced. D-SNP now exceeds 6 million enrollees, and C-SNP grew 34% this year. Carriers need to know what qualifying consumers expect from a SNP product and what they need to feel from a SNP service.
Our 2027 study examines the product features Duals value most, how the potential return of drug copays changes design priorities, and which marketing channels may reach Duals better. It also shows what sales professionals should focus on to match their approach to these beneficiaries. Plus, this year we offer an expanded look at AI and digital shopping, as well as a brand awareness section.
What’s New
- Expanded digital shopping experience. Examines how consumers use AI for shopping generally and for health insurance information specifically. It also covers how they use AI for tasks like checking symptoms and treatment options.
- New brand awareness and impression section. Gives particular attention to the growing C-SNP market.